# P230016: MAGE-A4 IHC 1F9 pharmDx

- Pathway: PMA
- Applicant: Agilent Technologies, Inc.
- Decided: Aug 1, 2024 after 458 days
- Product code: SBL (Immunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4)
- Device class: 3
- Regulation: 21 CFR 864.1860
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. PMA decisions do not claim a predicate device.

Source page: https://510kreport.com/device/P230016
Methodology: https://510kreport.com/methodology